DARE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DARE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Dare Bioscience's Book Value per Share for the quarter that ended in Mar. 2024 was $-0.11.
During the past 12 months, Dare Bioscience's average Book Value per Share Growth Rate was -287.90% per year. During the past 3 years, the average Book Value per Share Growth Rate was -21.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 12 years, the highest 3-Year average Book Value per Share Growth Rate of Dare Bioscience was 82.90% per year. The lowest was -67.90% per year. And the median was -14.55% per year.
For the Biotechnology subindustry, Dare Bioscience's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Dare Bioscience's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Dare Bioscience's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
Dare Bioscience (NAS:DARE) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Thank you for viewing the detailed overview of Dare Bioscience's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Sophia Nnenna Ononye-onyia | director | 1270 AVE OF THE AMERICAS, 7TH FL - 1026, NEW YORK NY 10020 |
Sabrina Martucci Johnson | director, officer: Chef Executive Officer | 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037 |
John A Fair | officer: Chief Strategy Officer | C/O DARE BIOSCIENCE, INC., 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037 |
Cheryl R Blanchard | director | C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580 |
Roger Hawley | director | 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO CA 92122 |
Gregory W Matz | director | 1 WHITE OAK WAY, NOVATO CA 94949 |
Jessica D. Grossman | director | C/O DARE BIOSCIENCE, INC., 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037 |
Lisa Walters-hoffert | officer: Chief Financial Officer | C/O DARE BIOSCIENCE, INC., 10210 CAMPUS POINT DRIVE, SUITE 150, SAN DIEGO CA 92121 |
Robin Joan Steele | director | 3280 BAYSHORE BOULEVARD, BRISBANE CA 94005 |
Scott Eliasof | officer: SVP, Chief Scientific Officer | C/O CERULEAN PHARMA INC., 35 GATEHOUSE DRIVE, WALTHAM MA 02451 |
David R Walt | director | 5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
Adrian Senderowicz | officer: SVP, Chief Medical Officer | C/O PUMA BIOTECHNOLOGY, INC., 10880 WILSHIRE BOULEVARD, SUITE 2150, LOS ANGELES CA 90024 |
Stuart A Arbuckle | director | VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY ST., CAMBRIDGE MA 02139 |
Alejandra Carvajal | officer: VP, General Counsel | C/O CERULEAN PHARMA INC., 840 MEMORIAL DRIVE, 5TH FLOOR, CAMBRIDGE MA 02139 |
James E Oneill | officer: Principal Accounting Officer | 15 GREENBRIAR CIRCLE, ANDOVER MA 01810 |
From GuruFocus
By sperokesalga sperokesalga • 04-20-2023
By Marketwired • 09-21-2023
By Marketwired • 09-20-2023
By Marketwired • 08-09-2023
By Marketwired • 06-21-2023
By Marketwired • 07-11-2023
By sperokesalga sperokesalga • 06-21-2023
By Marketwired • 08-10-2023
By Marketwired • 08-30-2023
By sperokesalga sperokesalga • 05-04-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.